SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
// Yun Hak Kim 1, * , Dae Cheon Jeong 2, * , Kyoungjune Pak 3 , Myoung-Eun Han 1 , Ji-Young Kim 1 , Liu Liangwen 1 , Hyun Jin Kim 4 , Tae Woo Kim 5 , Tae Hwa Kim 6 , Dong Woo Hyun 7 and Sae-Ock Oh 1 1 Department of Anatomy, School of medicine, Pusan National University, Yangsan, Republic of Korea 2 Department of Statistics, Korea University, Seoul 02841, Republic of Korea 3 Department of Nuclear Medicine, Pusan National University Hospital, Busan, Republic of Korea 4 Eco-friendly new materials research center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea 5 Department of Orthopaedic Surgery, Pusan National University Hospital, Yangsan, Republic of Korea 6 Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea 7 Department of General Surgery, Pusan National University Hospital, Busan, Republic of Korea * These authors contributed equally to this work Correspondence to: Sae-Ock Oh, email: hedgehog@pusan.ac.kr Keywords: hepatocellular carcinoma (HCC), solute carrier 2A (SLC2A), glucose transporter (GLUT), the cancer genome atlas (TCGA), 2- 18 fluoro-deoxy-D-glucose ( 18 FDG) Received: June 10, 2017 Accepted: July 25, 2017 Published: August 14, 2017 ABSTRACT High rates of glucose transport via solute carrier (SLC2A, GLUT) family members are required to satisfy the high metabolic demands of cancer cells, and because of this characteristic of cancer cells 2- 18 fluoro-deoxy-D-glucose ( 18 FDG)-PET has become a powerful diagnostic tool. However, its sensitivity for hepatocellular carcinoma (HCC) is lower than for other malignancies, which suggests SLC2A family members are differentially expressed in HCC. In the present study, the expression patterns of SLC2A family members in tumor tissues and their associations with HCC progression were analyzed using data obtained from The Cancer Genome Atlas (TCGA). It was found that the expression of SLC2A2 (GLUT2) was higher in HCC than those of other members of the SLC2A family. The associations of the expression levels of SLC2A family members and previously known prognostic factors with clinical stages were examined using the T -test or the Mann-Whitney U test, and interestingly, SLC2A2 expression was found to be associated with an advanced clinical stage ( p = 0.0015). Furthermore, Kaplan-Meier analysis using the log-rank or the Gehan-Breslow-Wilcoxon test showed SLC2A2 expression was positively associated with overall survival ( p < 0.001, Gehan-Breslow-Wilcoxon test and p = 0.0145 by multivariate Cox regression). The prognostic significance of SLC2A2 was similar in both early and late stages. However, it was more significant in HCC patients without alcohol consumption history and hepatitis C infection. Taken together, SLC2A2 was associated with clinical stages and independently associated with overall survival in patients with HCC. We suggest that SLC2A2 be considered a new prognostic factor for HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529 · cited 2×
“Many HCC patients have advanced disease at time of diagnosis, and this results in poor prognoses and high mortalities [22, 24].”
BackgroundUno, H., Cai, T., Pencina, M. J., D'Agostino, R. B., & Wei, L. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4154 · Cited by 1,535 · cited 1×
“To evaluate the discriminatory accuracy as continuous value, we used UNO’s C-index [59] in the time-dependent Area Under the Curve (AUC) analysis and AUC value in Receiver Operating Chracteristic (ROC) curve analysis at 5 years.”
MethodMolecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
Glucose transporters in the 21st Century
Thorens, B., & Mueckler, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00712.2009 · Cited by 1,013
GLUT2, glucose sensing and glucose homeostasis
Thorens, B. (2015) · Diabetologia · doi:10.1007/s00125-014-3451-1 · Cited by 722
Joost, H.-G., & Thorens, B. (2001) · Molecular Membrane Biology · doi:10.1080/09687680110090456 · Cited by 719
Metabolic positron emission tomography imaging in cancer detection and therapy response
Zhu, A., Lee, D., & Shim, H. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.11.012 · Cited by 368 · cited 2×
“Cancer cells acquire energy from different various sources, including glucose and fructose, to satisfy their high metabolic demands, and glucose and related hexoses are transported into cells via glucose transporter (GLUT) family (Solute carrier, SLC2A family) [1, 2].”
BackgroundMethodPak, K., Cheon, G. J., Nam, H.-Y., Kim, S.-J., Kang, K. W., Chung, J.-K., Kim, E. E., & Lee, D. S. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.133801 · Cited by 301 · cited 1×
“To obtain enough energy, cancer cells up-regulate the expressions of glucose transporters (GLUTs), especially SLC2A1, which has high affinity for glucose [11, 12, 41].”
BackgroundSelf-citationHigashi, K., Ueda, Y., Sakurai, A., MingWang, X., Xu, L., Murakami, M., Seki, H., Oguchi, M., Taki, S., Nambu, Y., et al. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000367 · Cited by 210
Cited by
Glucose transporters in cancer – from tumor cells to the tumor microenvironment
Ancey, P., Contat, C., & Meylan, E. (2018) · The FEBS Journal · doi:10.1111/febs.14577 · Cited by 514
Metabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
Ma, Y., Wang, W., Idowu, M. O., Oh, U., Wang, X.-Y., Temkin, S. M., & Fang, X. (2018) · Cancers · doi:10.3390/cancers11010033 · Cited by 145
“For example, GLUT2 is more markedly elevated than other GLUTs in hepatocellular carcinoma, and a strong expression of GLUT2 correlates with poor overall patient survival [14].”
BackgroundThe Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58
Metadata
- Authors
- Kim, Y. H., Jeong, D. C., Pak, K., Han, M.-E., Kim, J.-Y., Liangwen, L., Kim, H. J., Kim, T. W., Kim, T. H., Hyun, D. W., & Oh, S.-O.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-08-14
- Volume
- 8
- Issue
- 40
- Pages
- 68381-68392
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2748071788
- Cited by
- 102
- References
- 11
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.